• Je něco špatně v tomto záznamu ?

Potential Role of Bioactive Lipids in Rheumatoid Arthritis

W. Torres, M. Chávez-Castillo, JL. Peréz-Vicuña, R. Carrasquero, MP. Díaz, Y. Gomez, P. Ramírez, C. Cano, J. Rojas-Quintero, M. Chacín, M. Velasco, JB. de Sanctis, V. Bermudez

. 2021 ; 27 (44) : 4434-4451. [pub] -

Jazyk angličtina Země Spojené arabské emiráty

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012551

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that involves a pathological inflammatory response against articular cartilage in multiple joints throughout the body. It is a complex disorder associated with comorbidities such as depression, lymphoma, osteoporosis, and cardiovascular disease (CVD), which significantly deteriorate patients' quality of life and prognosis. This has ignited a large initiative to elucidate the physiopathology of RA, aiming to identify new therapeutic targets and approaches in its multidisciplinary management. Recently, various lipid bioactive products have been proposed to have an essential role in this process, including eicosanoids, specialized pro-resolving mediators, phospholipids/sphingolipids, and endocannabinoids. Dietary interventions using omega-3 polyunsaturated fatty acids or treatment with synthetic endocannabinoid agonists have been shown to significantly ameliorate RA symptoms. Indeed, the modulation of lipid metabolism may be crucial in the pathophysiology and treatment of autoimmune diseases.

000      
00000naa a2200000 a 4500
001      
bmc22012551
003      
CZ-PrNML
005      
20220506130402.0
007      
ta
008      
220425s2021 ts f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1381612827666210525164734 $2 doi
035    __
$a (PubMed)34036919
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Torres, Wheeler $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
245    10
$a Potential Role of Bioactive Lipids in Rheumatoid Arthritis / $c W. Torres, M. Chávez-Castillo, JL. Peréz-Vicuña, R. Carrasquero, MP. Díaz, Y. Gomez, P. Ramírez, C. Cano, J. Rojas-Quintero, M. Chacín, M. Velasco, JB. de Sanctis, V. Bermudez
520    9_
$a Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that involves a pathological inflammatory response against articular cartilage in multiple joints throughout the body. It is a complex disorder associated with comorbidities such as depression, lymphoma, osteoporosis, and cardiovascular disease (CVD), which significantly deteriorate patients' quality of life and prognosis. This has ignited a large initiative to elucidate the physiopathology of RA, aiming to identify new therapeutic targets and approaches in its multidisciplinary management. Recently, various lipid bioactive products have been proposed to have an essential role in this process, including eicosanoids, specialized pro-resolving mediators, phospholipids/sphingolipids, and endocannabinoids. Dietary interventions using omega-3 polyunsaturated fatty acids or treatment with synthetic endocannabinoid agonists have been shown to significantly ameliorate RA symptoms. Indeed, the modulation of lipid metabolism may be crucial in the pathophysiology and treatment of autoimmune diseases.
650    12
$a revmatoidní artritida $x komplikace $7 D001172
650    12
$a autoimunitní nemoci $x farmakoterapie $7 D001327
650    12
$a kyseliny mastné omega-3 $x terapeutické užití $7 D015525
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x metabolismus $7 D007249
650    _2
$a metabolismus lipidů $7 D050356
650    _2
$a kvalita života $7 D011788
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chávez-Castillo, Mervin $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Peréz-Vicuña, José L $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Carrasquero, Rubén $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Díaz, María P $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Gomez, Yosselin $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Ramírez, Paola $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Cano, Clímaco $u Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela
700    1_
$a Rojas-Quintero, Joselyn $u Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
700    1_
$a Chacín, Maricarmen $u Universidad Simón Bolivar, Facultad de Ciencias de la Salud, Barranquilla, Colombia
700    1_
$a Velasco, Manuel $u Universidad Central de Venezuela, Escuela de Medicina Jose María Vargas, Caracas, Venezuela
700    1_
$a de Sanctis, Juan Bautista $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Bermudez, Valmore $u Universidad Simon Bolívar, Facultad de Ciencias de la Salud, Barranquilla, Colombia
773    0_
$w MED00007893 $t Current pharmaceutical design $x 1873-4286 $g Roč. 27, č. 44 (2021), s. 4434-4451
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34036919 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130355 $b ABA008
999    __
$a ok $b bmc $g 1789950 $s 1163752
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 27 $c 44 $d 4434-4451 $e - $i 1873-4286 $m Current pharmaceutical design $n Curr Pharm Des $x MED00007893
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace